Related references
Note: Only part of the references are listed.Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
R. T. Bryan et al.
BRITISH JOURNAL OF CANCER (2014)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2014)
OPINION The future of bladder cancer care in the USA
Alan L. Kaplan et al.
NATURE REVIEWS UROLOGY (2014)
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
Sandra Rebouissou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Shedding of Soluble Epidermal Growth Factor Receptor (sEGFR) Is Mediated by a Metalloprotease/Fibronectin/Integrin Axis and Inhibited by Cetuximab
Jason A. Wilken et al.
BIOCHEMISTRY (2013)
Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome
Amanda G. Hansen et al.
CANCER RESEARCH (2013)
A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine
Raju Kandimalla et al.
CLINICAL CANCER RESEARCH (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Marko Babjuk et al.
EUROPEAN UROLOGY (2013)
Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells
Kamila A. Adamczyk et al.
LIFE SCIENCES (2011)
The West Midlands Bladder Cancer Prognosis Programme: rationale and design
Maurice P. Zeegers et al.
BJU INTERNATIONAL (2010)
Towards a knowledge-based Human Protein Atlas
Mathias Uhlen et al.
NATURE BIOTECHNOLOGY (2010)
Shotgun proteome analysis utilising mixed mode (reversed phase-anion exchange chromatography) in conjunction with reversed phase liquid chromatography mass spectrometry analysis
Helen L. Phillips et al.
PROTEOMICS (2010)
Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR positive advanced colorectal cancer treated with gefitinib?
M. G. Zampino et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells
Marianela Perez-Torres et al.
EXPERIMENTAL CELL RESEARCH (2008)
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach
Esteban Orenes-Pinero et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma
Y. Lemos-Gonzalez et al.
BRITISH JOURNAL OF CANCER (2007)
Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
G Hudelist et al.
EUROPEAN JOURNAL OF CANCER (2006)
Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE/ADAM17
M Zatovicova et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
